Chemoprevention of prostate cancer with selenium: an update on current clinical trials and preclinical findings.

@article{Meuillet2004ChemopreventionOP,
  title={Chemoprevention of prostate cancer with selenium: an update on current clinical trials and preclinical findings.},
  author={Emmanuelle J. Meuillet and Suzanne Stratton and Durga Prasad Cherukuri and Anne-Christine Goulet and Jacob D. Kagey and Bruce Porterfield and Mark A. Nelson},
  journal={Journal of cellular biochemistry},
  year={2004},
  volume={91 3},
  pages={443-58}
}
Prostate cancer is the most common cancer diagnosed and the second leading cause of cancer-related deaths in men in the United States. The etiological factors that give rise to prostate cancer are not known. Therefore, it is not possible to develop primary intervention strategies to remove the causative agents from the environment. However, secondary intervention strategies with selenium (Se) compounds and other agents represent a viable option to reduce the morbidity and mortality of prostate… CONTINUE READING

From This Paper

Topics from this paper.
26 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

Similar Papers

Loading similar papers…